France Aesthetic Medicine Market Size, Share, and COVID-19 Impact Analysis, By Product (Botulinum Toxin, Dermal Filler, Chemical Peel, Microdermabrasion, and Others), By End-User (Aesthetic Clinics, Hospitals, and Others), and France Aesthetic Medicine Market Insights, Industry Trend, Forecasts to 2033

Industry: Healthcare

RELEASE DATE Jun 2024
REPORT ID SI4481
PAGES 250
REPORT FORMAT PathSoft

France Aesthetic Medicine Market Insights Forecasts to 2033

  • The France Aesthetic Medicine Market Size was valued at USD 0.5 Billion in 2023
  • The Market Size is Growing at a CAGR of 10.03% from 2023 to 2033
  • The France Aesthetic Medicine Market Size is Expected to reach USD 1.3 Billion by 2033

 

France Aesthetic Medicine Market

Get more details on this report -

Request Free Sample PDF

 

The France Aesthetic Medicine Market Size is anticipated to exceed USD 1.3 Billion by 2033, Growing at a CAGR of 10.03% from 2023 to 2033. The Growing awareness about cosmetic procedures, adoption of non and minimally invasive aesthetic procedures are driving the growth of the aesthetic medicine market in the France.     

 

Market Overview

Aesthetic medicine is a branch of modern medicine that focuses on altering natural or acquired unwanted appearance through the treatment of conditions including scars, wrinkles, skin laxity, liver spots, moles, excess fat, skin discoloration, spider veins, cellulite, unwanted hair, and any unwanted externally visible appearance. One of the most effective and versatile methods for skin regeneration is chemical peeling. Chemical peels, dermal fillers, and BTX-A injections work synergistically to provide beneficial effects. These rejuvenating procedures significantly increase the satisfaction rate of the patients and are relatively easy to adopt by any practicing dermatologist. The field of aesthetic medicine has expanded a wide range of alternatives including non-surgical facelifts and injectables. The use of advanced skincare devices that provide at-home treatments is a growing trend in the field of aesthetic medicine, offering patients the convenience of performing treatments in the comfort of their own homes, as well as a more affordable alternative to in-office procedures. Technologies such as LED light therapy, microcurrents, and ultrasound are utilized to improve skin health and appearance.

 

Report Coverage

This research report categorizes the market for the France aesthetic medicine market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Aesthetic Medicine market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France aesthetic medicine market.

 

France Aesthetic Medicine Market Report Coverage

Report CoverageDetails
Base Year:2023
Market Size in 2023 :USD 0.5 Billion
Forecast Period:2023 – 2033
Forecast Period CAGR 2023 – 2033 :10.03%
023 – 2033 Value Projection:USD 1.3 Billion
Historical Data for:2019-2022
No. of Pages:250
Tables, Charts & Figures:110
Segments covered:By Product, By End-User
Companies covered:: Dermaceutic Laboratoire, Johnson & Johnson, AbbVie Inc. (AILergan Plc), Bioxis Pharmaceuticals, Ipsen Pharma, and Others key vendors
Pitfalls & Challenges:Covid-19 Impact, Challenge, Future,Growth and Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The increasing awareness about cosmetic procedures, and adoption of non and minimally invasive aesthetic procedures are driving the market demand for aesthetic medicine.  An increase in product launches and an increase in the demand for facial surgeries are also contributing to fueling the market growth. Furthermore, the increase in several cosmetic and plastic surgeries is anticipated to propel the France aesthetic medicine market.

 

Restraining Factors

Stringent safety regulations for aesthetic procedures and related adverse effects are restraining the France aesthetic medicine market.

 

Market Segmentation

The France Aesthetic Medicine Market share is classified into product and end-user

 

  • The dermal filler segment is expected to hold a significant share of the France Aesthetic Medicine market during the forecast period.   

The France aesthetic medicine market is segmented by product into botulinum toxin, dermal filler, chemical peel, microdermabrasion, and others. Among these, the dermal filler segment is expected to hold a significant share of the France aesthetic medicine market during the forecast period. Dermal fillers are injectable implants used as soft tissue fillers, lip and facial fillers, and wrinkle fillers that help to create a smoother and/or fuller appearance in the face. It has widespread application in the aesthetic industry. The advantage of dermal filler over other treatment modalities drives the market in the dermal filler segment.     

 

  • The hospitals segment is expected to hold the largest share of the France aesthetic medicine market during the forecast period.       

Based on the end-user, the France aesthetic medicine market is divided into aesthetic clinics, hospitals, and others. Among these, the hospitals segment is expected to hold the largest share of the France aesthetic medicine market during the forecast period. The availability of advanced equipment in hospitals makes it the safest and most high-tech surgical unit for aesthetic medicine. The growing number of plastic surgeries in France is driving the market demand in the hospitals segment.       

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France aesthetic medicine market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Dermaceutic Laboratoire
  • Johnson & Johnson
  • AbbVie Inc. (AILergan Plc)
  • Bioxis Pharmaceuticals
  • Ipsen Pharma
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Recent Developments

  • In June 2021, Galderma announced that Alluzience has completed its European decentralized procedure resulting in a positive decision for the first ready-to-use neuromodulator, a wrinkle relaxing injection, in Europe.

 

Market Segment

This study forecasts revenue at France, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the France Aesthetic Medicine Market based on the below-mentioned segments:

 

France Aesthetic Medicine Market, By Product

  • Botulinum Toxin
  • Dermal Filler
  • Chemical Peel
  • Microdermabrasion
  • Others

 

France Aesthetic Medicine Market, By End-User

  • Aesthetic Clinics
  • Hospitals
  • Others

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies